Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1955 1
1957 1
1958 1
1961 1
1964 2
1965 2
1966 3
1968 2
1969 2
1970 3
1971 7
1972 3
1973 2
1974 4
1975 3
1976 1
1977 5
1978 2
1979 1
1980 3
1981 3
1982 1
1983 3
1984 3
1985 6
1986 7
1987 10
1988 10
1989 9
1990 13
1991 17
1992 16
1993 11
1994 19
1995 6
1996 9
1997 4
1998 9
1999 13
2000 14
2001 10
2002 18
2003 13
2004 13
2005 25
2006 29
2007 31
2008 48
2009 32
2010 27
2011 46
2012 67
2013 79
2014 71
2015 93
2016 108
2017 100
2018 105
2019 118
2020 176
2021 216
2022 240
2023 254
2024 232
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,154 results

Results by year

Filters applied: . Clear all
Page 1
Adult attention deficit hyperactivity disorder: a comprehensive review.
Williams OC, Prasad S, McCrary A, Jordan E, Sachdeva V, Deva S, Kumar H, Mehta J, Neupane P, Gupta A. Williams OC, et al. Among authors: kumar h. Ann Med Surg (Lond). 2023 Apr 12;85(5):1802-1810. doi: 10.1097/MS9.0000000000000631. eCollection 2023 May. Ann Med Surg (Lond). 2023. PMID: 37228994 Free PMC article.
Novel therapies for metastatic prostate cancer.
Jang A, Lanka SM, Ruan HT, Kumar HLS, Jia AY, Garcia JA, Mian OY, Barata PC. Jang A, et al. Among authors: kumar hls. Expert Rev Anticancer Ther. 2023 Jul-Dec;23(12):1251-1263. doi: 10.1080/14737140.2023.2290197. Epub 2023 Dec 8. Expert Rev Anticancer Ther. 2023. PMID: 38030394 Review.
Lasers in glaucoma.
Kumar H, Mansoori T, Warjri GB, Somarajan BI, Bandil S, Gupta V. Kumar H, et al. Indian J Ophthalmol. 2018 Nov;66(11):1539-1553. doi: 10.4103/ijo.IJO_555_18. Indian J Ophthalmol. 2018. PMID: 30355858 Free PMC article. Review.
Efficacy and safety of once-weekly semaglutide versus daily canagliflozin as add-on to metformin in patients with type 2 diabetes (SUSTAIN 8): a double-blind, phase 3b, randomised controlled trial.
Lingvay I, Catarig AM, Frias JP, Kumar H, Lausvig NL, le Roux CW, Thielke D, Viljoen A, McCrimmon RJ. Lingvay I, et al. Among authors: kumar h. Lancet Diabetes Endocrinol. 2019 Nov;7(11):834-844. doi: 10.1016/S2213-8587(19)30311-0. Epub 2019 Sep 17. Lancet Diabetes Endocrinol. 2019. PMID: 31540867 Clinical Trial.
Orphan drugs: Indian perspective.
Kumar H, Sarma P, Medhi B. Kumar H, et al. Indian J Pharmacol. 2017 Jul-Aug;49(4):267-269. doi: 10.4103/ijp.IJP_646_17. Indian J Pharmacol. 2017. PMID: 29326485 Free PMC article. No abstract available.
2,154 results